XLABW Exascale Labs Holdings Inc. - Warrant
NASDAQ · View on SEC EDGAR ↗ 10-K/10-Q Sep 28, 2026
$0.20
· of 52w range
· above low
· to high
$0.0552w low
$0.6052w high
EPS
$-8108.26
Revenue
$15M
your badges
52W Range
$0–$1
Analyst Rating
·
Price Target
·
P/E
·
ROE
63.7%
Net Profit Margin
-82.0%
Your badge strip is empty — pin a metric anywhere on this page.
XLABW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.20
EPS
$-8108.26
Revenue
$15M
ROE
63.7%
52W Range
$0–$1
XLABW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$15M2025-06-30 → 2026-06-30
EPS$-8108.262025-06-30 → 2026-06-30
Net margin-82.0%2026-06-30 → 2026-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | XLABW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 16.3% | · | · | · | |
| Operating Margin | -32.4% | · | · | · | |
| EBITDA Margin | -32.4% | · | · | · | |
| Pretax Margin | -82.0% | · | · | · | |
| Net Profit Margin | -82.0% | · | · | · | |
| ROA | -173.1% | · | · | · | |
| ROE | 63.7% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | XLABW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.2 | · | · | · | |
| Quick Ratio | 0.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | XLABW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 111.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | XLABW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 2.1 | · | · | · | |
| Receivables Turnover | 22.8 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue | $15M | $7M | |
| Cost of Revenue | $12M | $6M | |
| Gross Profit | $2M | $1M | |
| R&D Expense | $5M | $3M | |
| SG&A Expense | $1M | $363.0K | |
| Operating Expenses | $7M | $4M | |
| Operating Income | $-5M | $-3M | |
| Pretax Income | $-12M | $-8M | |
| Net Income | $-12M | $-8M | |
| EPS (Basic) | $-8108.26 | $-5106.44 | |
| EPS (Diluted) | $-8108.26 | $-5106.44 | |
| Shares (Basic) | 1,500 | 1,500 | |
| Shares (Diluted) | 1,500 | 1,500 | |
| EBITDA | $-5M | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Cash & Equivalents | $3M | $4M | |
| Receivables | $1M | $152.5K | |
| Current Assets | $7M | $7M | |
| PP&E (Net) | $12.8K | $19.6K | |
| PP&E (Gross) | $29.2K | $29.9K | |
| Total Assets | $7M | $7M | |
| Accounts Payable | $916.4K | $90.0K | |
| Current Liabilities | $32M | $20M | |
| Total Liabilities | $32M | $20M | |
| Common Stock | · | $15 | |
| Paid-in Capital | $220.6K | $220.6K | |
| Retained Earnings | $-25M | $-13M | |
| Stockholders' Equity | $-25M | $-13M | |
| Liabilities + Equity | $7M | $7M | |
| Shares Outstanding | · | 1,500 |
Cash Flow
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Stock-based Comp | $0 | $153.3K | |
| Operating Cash Flow | $-3M | $-1M | |
| CapEx | · | $2.1K | |
| Investing Cash Flow | $1M | $-2.1K | |
| Financing Cash Flow | $-190.0K | $4M |
Profitability
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Gross Margin | 16.3% | · | |
| Operating Margin | -32.4% | · | |
| Net Margin | -82.0% | · | |
| Pretax Margin | -82.0% | · | |
| EBITDA Margin | -32.4% | · | |
| ROA | -173.1% | · | |
| ROE | 63.7% | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Current Ratio | 0.2 | · | |
| Quick Ratio | 0.1 | · |
Efficiency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Asset Turnover | 2.1 | · | |
| Receivables Turnover | 22.8 | · |
Per Share
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue / Share | $9881.87 | · | |
| Cash Flow / Share | $-1836.42 | · | |
| EPS (TTM) | $-8108.26 | · |
Growth Rates
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue YoY | 111.3% | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue TTM | $15M | · | |
| Net Income TTM | $-12M | · |
No quarterly filings for XLABW
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Revenue | $15M | $7M |
| Gross Margin % | 16.3% | · |
| Operating Margin % | -32.4% | · |
| Net Income | $-12M | $-8M |
| Diluted EPS | $-8108.26 | $-5106.44 |
| Metric | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Current Ratio | 0.2 | · |
| Quick Ratio | 0.1 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Company insiders 4 insiders · 1 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hoan Soo Lee | Chief Executive Officer | Oct. 6, 2026 A | · | 0 | 0 | $0 |
| David Edward Card | Director | Oct. 6, 2026 A | · | 0 | 0 | $0 |
| Jaeyoung Shin | Director | Oct. 6, 2026 A | · | 0 | 0 | $0 |
| Shachar Kariv | Director | Oct. 6, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-K filed Sep 28, 2026